Traditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis

Traditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis

Recent findings highlight the emerging role of the endocannabinoid system in the control of symptoms and disease progression in multiple sclerosis (MS). MS is a chronic, immune-mediated, demyelinating disorder of the central nervous system with no cure so far. It is widely reported in the literature...

Full description

Bibliographic Details
Main Authors: Francesca Gado, Maria Digiacomo, Marco Macchia, Simone Bertini, Clementina Manera
Format: Article
Language:English
Published: MDPI AG 2018-08-01
Series:Medicines
Subjects:
multiple sclerosis
endocannabinoid system
cannabinoid receptors
monoacylglycerol lipase (MAGL) inhibitors
fatty acid amide hydrolase (FAAH) inhibitors
arachidonoylethanolamine (AEA) reuptake inhibitors
Online Access:http://www.mdpi.com/2305-6320/5/3/91

Internet

http://www.mdpi.com/2305-6320/5/3/91

Similar Items